Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elsiglutide dose-finding for prevention of chemotherapy-induced diarrhea in colorectal cancer
2014-000998-39Phase 2Completed
- Sponsor
- Helsinn
- Start
- Jul 2014
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of elsiglutide in diarrhea (4 arms), sponsored by Helsinn. Started Jul 2014; status: completed.
02
Drugs
elsiglutide
03
Conditions
diarrhea
Beyond the preview
Go deeper on 2014-000998-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000998-39.